Manufacturer
Tripoint Therapeutics
- Products listed
- 3
- Molecules
- 2
- Therapy areas
- 1
Tripoint Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Tripoint Therapeutics, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Tripoint Therapeutics products through licensed channels, with the documents your regulator needs.
Neurology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Elepsia XR 1000 MG 1000 mg extended-release tabletOral | Levetiracetam | US FDA | Available on request |
| Elepsia XR 1500 MG 1500 mg extended-release tabletOral | Levetiracetam | US FDA | Available on request |
Other products
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Carbinoxamine 6 mg tabletOralGeneric name | Carbinoxamine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Tripoint Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.